Skip to main content

Jonathan Drachman

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jonathan Drachman

Jonathan Drachman is recorded as CFO at Neurogene Inc. (NGNE). Neurogene Inc. reported in an 8-K filed April 3, 2023 that Jonathan Drachman resigned as President, Chief Executive Officer, principal executive and financial officer and director, effective March 31, 2023. The proxy statement of Neurogene Inc. reports total compensation of $549,983 for Jonathan Drachman in fiscal 2023, including a base salary of $113,544. Disclosed compensation is on record for 3 fiscal years.

“The Executive Officer Appointments occurred in connection with Dr. Jonathan Drachman, M.D.'s resignation from his role as President, Chief Executive Officer, principal executive and financial officer and director of the Company as of the Effective Date, as previously announced on March 6, 2023.”
Neurogene Inc. Form 8-K, filed April 3, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Neurogene Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 Neurogene Inc. (NGNE) $113,544 $549,983
2022 Neurogene Inc. (NGNE) $452,985 $902,179
2019 Neurogene Inc. (NGNE) $137,304 $3,823,038

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.